Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

INVO Fertility (IVF) EBIT Margin (2016 - 2025)

INVO Fertility (IVF) has disclosed EBIT Margin for 15 consecutive years, with 93.08% as the latest value for Q3 2025.

  • Quarterly EBIT Margin fell 234.0% to 93.08% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 273.36% through Sep 2025, down 17429.0% year-over-year, with the annual reading at 29.24% for FY2024, 19479.0% up from the prior year.
  • EBIT Margin for Q3 2025 was 93.08% at INVO Fertility, up from 160.44% in the prior quarter.
  • The five-year high for EBIT Margin was 2051.28% in Q4 2022, with the low at 1835.17% in Q2 2022.
  • Average EBIT Margin over 5 years is 394.01%, with a median of 160.44% recorded in 2025.
  • The sharpest move saw EBIT Margin skyrocketed 190837bps in 2022, then tumbled -216045bps in 2023.
  • Over 5 years, EBIT Margin stood at 142.91% in 2021, then soared by 1335bps to 2051.28% in 2022, then tumbled by -105bps to 109.17% in 2023, then surged by 249bps to 163.18% in 2024, then tumbled by -157bps to 93.08% in 2025.
  • According to Business Quant data, EBIT Margin over the past three periods came in at 93.08%, 160.44%, and 1044.93% for Q3 2025, Q2 2025, and Q1 2025 respectively.